Kearns-Sayre syndrome: a case report and review of cardiovascular complications.

Timothy J Young, Amit K Shah, Mun Heng Lee, David L Hayes

Journal: Pacing and clinical electrophysiology : PACE 2005;28(5):454-7

PMID: 15869681

Abstract

Kearns-Sayre syndrome (KSS) is a rare genetic abnormality. Classified as a mitochondrial cytopathy, the primary pathology of this syndrome is a disturbance of mitochondrial DNA, which codes for the proteins required for the respiratory chain reaction. Onset occurs before age 20, and is manifest as chronic progressive external ophthalmoplegia and retinal degeneration. Management issues of KSS include prophylactic cardiac pacing for conduction defects, which has been shown to improve survival. Other clinical considerations relate to dietary supplements to attempt to control the progressive effects of the disease.

Address: Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.